Opening book details…
About this book
Balancing Properties with Carboxylates: A Lead Optimization Campaign for Selective and Orally Active CDK9 Inhibitors by Yunsong Tong, Alan S. Florjancic, Rick F. Clark, Chunqiu Lai, Anthony Mastracchio, Gui-dong Zhu, Morey L. Smith, Peter J. Kovar, Bailin Shaw, Daniel H. Albert, Wei Qiu, Kenton L. Longenecker, Xiaoqin Liu, Amanda M. Olson, Donald J. Osterling, Stephen... is a book available to read on EtoBox.
- Author
- Yunsong Tong, Alan S. Florjancic, Rick F. Clark, Chunqiu Lai, Anthony Mastracchio, Gui-dong Zhu, Morey L. Smith, Peter J. Kovar, Bailin Shaw, Daniel H. Albert, Wei Qiu, Kenton L. Longenecker, Xiaoqin Liu, Amanda M. Olson, Donald J. Osterling, Stephen...
- Published
- 2021
- Language
- EN
More by Yunsong Tong, Alan S. Florjancic, Rick F. Clark, Chunqiu Lai, Anthony Mastracchio, Gui-dong Zhu, Morey L. Smith, Peter J. Kovar, Bailin Shaw, Daniel H. Albert, Wei Qiu, Kenton L. Longenecker, Xiaoqin Liu, Amanda M. Olson, Donald J. Osterling, Stephen...
Similar books
- Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1 — Andrew P. Degnan, Godwin K. Kumi, Christopher W. Allard, Erika V. Araujo, Walter L. Johnson, Kurt Zimmermann, Bradley C. Pearce, Steven Sheriff, Alan Futran, Xin Li, Gregory A. Locke, Dan You, John Morrison, Karen E. Parrish, Caitlyn Stromko, Anwar... (2021)
- Novel Potent Selective Orally Active S1P5 Receptor Antagonists — Bin Ma, Kevin M. Guckian, Xiao-gao Liu, Chunhua Yang, Bing Li, Robert Scannevin, Michaël Mingueneau, Annabelle Drouillard & Thierry Walzer (2021)
- Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors — Donghui Qin, Xiaojuan Lin, Zhi Liu, Yan Chen, Zhiliu Zhang, Chengde Wu, Linlin Liu, Yan Pan, Sylvie Laquerre, John Emery, Jeff Fergusson, Kimberly Roland, Rick Keenan, Allen Oliff, Sanjay Kumar, Mui Cheung & Dai-Shi Su (2021)
- Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain Inhibitors — Michael A. Clegg, Natalie H. Theodoulou, Paul Bamborough, Chun-wa Chung, Peter D. Craggs, Emmanuel H. Demont, Laurie J. Gordon, Gemma M. Liwicki, Alex Phillipou, Nicholas C. O. Tomkinson, Rab K. Prinjha & Philip G. Humphreys (2021)
- Discovery and Optimization of a Series of Benzofuran Selective ERAP1 Inhibitors: Biochemical and In Silico Studies — Safia Deddouche-Grass, Cyrielle Andouche, Felix Bärenz, Célia Halter, Arnaud Hohwald, Louison Lebrun, Nathalie Membré, Renaud Morales, Nicolas Muzet, Matthieu Poirot, Morgane Reynaud, Véronique Roujean, Fabienne Weber, André Zimmermann, Rama Heng &... (2021)
- Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2 — Minh H. Nguyen, Onur Atasoylu, Liangxing Wu, Kanishk Kapilashrami, Michelle Pusey, Karen Gallagher, Cheng-Tsung Lai, Peng Zhao, Joseph Barbosa, Kai Liu, Chunhong He, Colin Zhang, Evan D. Styduhar, Michael R. Witten, Yaoyu Chen, Luping Lin, Yan-ou Yang,... (2022)